for an Elevated Lifestyle
Balancing Nature and Science for an Elevated Lifestyle
One of the most recognized CBD-branded
products in the world
One of the most recognized CBD-branded
products in the world
FarmaSci Life products are distributed through our branded and third-party e-commerce sites, distributors, marketing partners, and brick and mortar retailers.
Our products are sold in all 50 states, 4 continents, and 17 countries worldwide.
We are at the intersection of a fast-growing wellness segment with 84 SKU’s formulated using natural, organic ingredients from our nationally recognized brands with award-winning flavors.
FarmaSci Life products are distributed through both our own branded and third-party e-commerce sites, distributors, marketing partners, and brick and mortar retailers.
Our products are sold in all 50 states, 4 continents, and 17 countries worldwide.
We are at the intersection of a fast-growing wellness segment with 84 SKU’s formulated using natural, organic ingredients from our nationally recognized brands with award-winning flavors.
We Are FarmaSciLife
We Are FarmaSciLife
Why Invest?
Why Invest?
"A Top Pick for 2022"
As one of the most trusted names in the CBD space, FarmaSci represents the evolution of our business model into CBD wellness, increasing our exposure to high-margin marketplaces alongside significant new C-suite expertise.
FSL is profitable and poised for substantial revenue growth through organic distribution, accretive platform acquisitions, and strategic alliances with sought-after brands in complementary markets.
As one of the most trusted names in the CBD space, FarmaSci represents the evolution of our business model into CBD wellness, increasing our exposure to high-margin marketplaces alongside significant new C-suite expertise.
FSL is profitable and poised for substantial revenue growth through organic distribution, accretive platform acquisitions, and strategic alliances with sought-after brands in complementary markets.
The CBD Phenomenon Is Going Mainstream
The CBD Phenomenon Is Going Mainstream
Join the "Green Rush"
Why has CBD become so popular, so fast?
Investment Highlights
Investment Highlights
GROWTH
OPPORTUNITIES
STRONG GROWTH
EXPECTATIONS
GROWTH
OPPORTUNITIES
STRONG GROWTH
EXPECTATIONS
Our Leadership Team
Our Leadership Team
John Maloney
John Maloney
Chairman & CEO
Mike Johnston
Cheryl Austin
Miguel Gomes
CFO
VP, Marketing &
CTO
Communications
Darin Delia
Matt Byrne
Heidi Decher
Director of Distribution
Director of Strategic
Creative Director
Partnerships
John Maloney
John Maloney
Chairman & CEO
Mike Johnston
Cheryl Austin
Miguel Gomes
CFO
VP, Marketing &
CTO
Communications
Darin Delia
Matt Byrne
Heidi Decher
Director of Distribution
Director of Strategic
Creative Director
Partnerships
Diagnosed Conditions & Target Markets
that Benefit from CBD
Diagnosed Conditions & Target Markets
that Benefit from CBD
- Anxiety & Depression
- Arthritis
- Insomnia
- Chronic Pain
- Memory Loss
- General Wellness & Immune Support
- Digestion
Anxiety affects more than 40 million people every year, while a further 16.1 million suffer from depression in the U.S.A. alone.
The global anxiety disorders and depression treatment market will exhibit a stellar growth of 28.2% in 2020. The market is projected to grow from USD 10.89 billion in 2020 to USD 13.03 billion in 2027 at a CAGR of 2.6% in the 2020-2027 period.
www.fortunebusinessinsights.com
58.5 million people are affected in the U.S.A.
The global rheumatoid arthritis therapeutics market size stood at USD 23,822.5 Million in 2017 and is projected to reach USD 33,958.4 Million by 2025, exhibiting a CAGR of 4.6% in the forecast period (2018-2025).
www.fortunebusinessinsights.com
Over 70 million Americans are affected every year.
American Sleep Association: Nearly 70 million Americans have a sleep disorder. Insomnia is the most common sleep disorder, with 30% of adults experiencing short-term insomnia.
The global market for sleep aids should grow from $81.2 billion in 2020 to $112.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.8% for the period of 2020-2025.
www.bccresearch.com
Over 50 million people suffer annually in the U.S.A.
The pain management market was valued at approximately USD 65,108 million in 2020, and it is expected to witness a revenue of USD 86,505 million in 2026, with a CAGR of 4.85% over the forecast period.
www.mordorintelligence.com
16 million people are affected every year in the U.S.A.
The North America memory supplements market size was estimated at USD 731.7 million in 2020 and is expected to reach USD 787.3 million in 2021.
www.grandviewresearch.com
More than 170 million Americans take dietary supplements.
The North American dietary supplements market size was estimated at USD 50,118.6 million in 2020 and is expected to reach USD 52,874.7 million in 2021.
www.grandviewresearch.com
Over 5 million adults in America use probiotics.
A National Health Interview Survey found that more than 5 million US adults use probiotics.
www.mdlinx.com
North America Probiotic Dietary Supplement Market was worth USD 1.56 billion in 2021, and is expected to grow at a CAGR of 6.5%, to reach USD 2.13 billion by 2026.
www.marketdataforecast.com
Anxiety affects more than 40 million people every year, while a further 16.1 million suffer from depression in the U.S.A. alone.
The global anxiety disorders and depression treatment market will exhibit a stellar growth of 28.2% in 2020. The market is projected to grow from USD 10.89 billion in 2020 to USD 13.03 billion in 2027 at a CAGR of 2.6% in the 2020-2027 period.
www.fortunebusinessinsights.com
58.5 million people are affected in the U.S.A.
The global rheumatoid arthritis therapeutics market size stood at USD 23,822.5 Million in 2017 and is projected to reach USD 33,958.4 Million by 2025, exhibiting a CAGR of 4.6% in the forecast period (2018-2025).
www.fortunebusinessinsights.com
Over 70 million Americans are affected every year.
American Sleep Association: Nearly 70 million Americans have a sleep disorder. Insomnia is the most common sleep disorder, with 30% of adults experiencing short-term insomnia.
The global market for sleep aids should grow from $81.2 billion in 2020 to $112.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.8% for the period of 2020-2025.
www.bccresearch.com
Over 50 million people suffer annually in the U.S.A.
The pain management market was valued at approximately USD 65,108 million in 2020, and it is expected to witness a revenue of USD 86,505 million in 2026, with a CAGR of 4.85% over the forecast period.
www.mordorintelligence.com
16 million people are affected every year in the U.S.A.
The North America memory supplements market size was estimated at USD 731.7 million in 2020 and is expected to reach USD 787.3 million in 2021.
www.grandviewresearch.com
More than 170 million Americans take dietary supplements.
The North American dietary supplements market size was estimated at USD 50,118.6 million in 2020 and is expected to reach USD 52,874.7 million in 2021.
www.grandviewresearch.com
Over 5 million adults in America use probiotics.
A National Health Interview Survey found that more than 5 million US adults use probiotics.
www.mdlinx.com
North America Probiotic Dietary Supplement Market was worth USD 1.56 billion in 2021, and is expected to grow at a CAGR of 6.5%, to reach USD 2.13 billion by 2026.
www.marketdataforecast.com
Our Brand Power
Our Brand Power
We Believe in Helping People Live Better
Our Customers Love Us
“A great change from taking prescribed meds for anxiety. Has helped me stay mentally healthy without the overly groggy feeling.” – Jeremy J.
“I have purchased CBD from multiple companies, and after being referred to BMH by a friend, I will never choose another company. Lots of research went into my purchase of several items, and none have disappointed. Fast delivery, quality products. I have been using their products for 4 months and have not lost any interest. Awesome referral program and rewards program as well! Customer for life.” – Brandon D.
“I have used several different brands of CBD Tinctures and I always come back to Blue Moon 1000 mg. when needing something for joint pain and/or anxiety. I can usually feel a difference within 15 minutes after I put the drops under my tongue.” – Trish R.
“A great change from taking prescribed meds for anxiety. Has helped me stay mentally healthy without the overly groggy feeling.” – Jeremy J.
“I have purchased CBD from multiple companies, and after being referred to BMH by a friend, I will never choose another company. Lots of research went into my purchase of several items, and none have disappointed. Fast delivery, quality products. I have been using their products for 4 months and have not lost any interest. Awesome referral program and rewards program as well! Customer for life.” – Brandon D.
“I have used several different brands of CBD Tinctures and I always come back to Blue Moon 1000 mg. when needing something for joint pain and/or anxiety. I can usually feel a difference within 15 minutes after I put the drops under my tongue.” – Trish R.
“A great change from taking prescribed meds for anxiety. Has helped me stay mentally healthy without the overly groggy feeling.” – Jeremy J.
“I have purchased CBD from multiple companies, and after being referred to BMH by a friend, I will never choose another company. Lots of research went into my purchase of several items, and none have disappointed. Fast delivery, quality products. I have been using their products for 4 months and have not lost any interest. Awesome referral program and rewards program as well! Customer for life.” – Brandon D.
“I have used several different brands of CBD Tinctures and I always come back to Blue Moon 1000 mg. when needing something for joint pain and/or anxiety. I can usually feel a difference within 15 minutes after I put the drops under my tongue.” – Trish R.
Financing Milestones
Financing Milestones
PATH TO INCREASED
GROWTH AND PROFITABILITY
USE OF PROCEEDS
PATH TO INCREASED
GROWTH AND PROFITABILITY
USE OF PROCEEDS
expand into C-Store Distribution, increase In-Store marketing spend, and relaunch the
Swiss Relief brand with new formulations and inventory. Increased sales forecasted
demand in Q1/Q2 is fueling significant product/SKU inventory requirements.
To the extent such information obtained from third party sources, there is a risk that the assumptions made and conclusions drawn by the Company based on such representations are not accurate. This document and the information available herein are not intended to provide you with any financial, accounting, tax, or legal advice. All figures unless stated otherwise are in $USD. This Presentation is confidential and not for distribution.
FORWARD-LOOKING STATEMENTS
Certain information contained in this presentation constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “target,” “project,” “estimate,” “intend,” “outlook”, “continue” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Forward-looking statements include, but are not limited to, the growth in the cannabis market, the size of revenue of the cannabis market, the Company’s future revenues, the construction of the Company’s facilities, the ability of the Company to obtain financing for the development of its projects, the Company’s business plan and access to future funding and projects, the ability of the Company to repay its loans, the Company’s financial forecasts, plans for expansion of the Company’s business, statements about potential market developments and trends, demand for the Company’s products and services and other statements that are not historical facts. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant legal, business, economic and competitive uncertainties and contingencies. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Such risks and uncertainties include but are not limited to, the fact that the Company is an early stage company with limited operating history and resources, execution of the Company’s business plan requires raising additional capital, the cannabis market is highly regulated and those regulations and enforcement priorities of governmental authorities may change, the cannabis market is highly competitive, technical advances in the industry as well as changing political and economic conditions present within the industry will impact the success of the Company/ Except as required by law, we disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. No forward-looking statement or projections can be guaranteed. Accordingly, you should not place undue reliance on any forward-looking statements or information.
To the extent such information obtained from third party sources, there is a risk that the assumptions made and conclusions drawn by the Company based on such representations are not accurate. This document and the information available herein are not intended to provide you with any financial, accounting, tax, or legal advice. All figures unless stated otherwise are in $USD. This Presentation is confidential and not for distribution.
FORWARD-LOOKING STATEMENTS
Certain information contained in this presentation constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “target,” “project,” “estimate,” “intend,” “outlook”, “continue” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Forward-looking statements include, but are not limited to, the growth in the cannabis market, the size of revenue of the cannabis market, the Company’s future revenues, the construction of the Company’s facilities, the ability of the Company to obtain financing for the development of its projects, the Company’s business plan and access to future funding and projects, the ability of the Company to repay its loans, the Company’s financial forecasts, plans for expansion of the Company’s business, statements about potential market developments and trends, demand for the Company’s products and services and other statements that are not historical facts. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant legal, business, economic and competitive uncertainties and contingencies. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Such risks and uncertainties include but are not limited to, the fact that the Company is an early stage company with limited operating history and resources, execution of the Company’s business plan requires raising additional capital, the cannabis market is highly regulated and those regulations and enforcement priorities of governmental authorities may change, the cannabis market is highly competitive, technical advances in the industry as well as changing political and economic conditions present within the industry will impact the success of the Company/ Except as required by law, we disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. No forward-looking statement or projections can be guaranteed. Accordingly, you should not place undue reliance on any forward-looking statements or information.